News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q



8/3/2010 9:49:16 AM

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ) announced today that it has filed its Form 10-Q with the Securities and Exchange Commission. APP Pharmaceuticals, Inc., which was acquired by Fresenius Kabi Pharmaceuticals Holding, Inc., is a member of the Fresenius Kabi Group. The Form 10-Q details the Company’s unaudited financial statements for the quarter ending June 30, 2010.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES